PVAM

Pacific View Asset Management Portfolio holdings

AUM $20.8M
1-Year Est. Return 20.08%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+20.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.8M
AUM Growth
-$71.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1 +$4.91M
2 +$4.72M
3 +$4.62M
4
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$4.61M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$4.61M

Sector Composition

1 Consumer Staples 59.86%
2 Industrials 22.5%
3 Technology 13.93%
4 Communication Services 0%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZWS icon
26
Zurn Elkay Water Solutions
ZWS
$7.93B
-93,183
SUM
27
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-22,759
SYNH
28
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-69,977
AERI
29
DELISTED
Aerie Pharmaceuticals
AERI
-120,230
ISBC
30
DELISTED
Investors Bancorp, Inc.
ISBC
-323,246
ARRY
31
DELISTED
Array Biopharma Inc
ARRY
-14,364
HZNP
32
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-58,902
MDGL icon
33
Madrigal Pharmaceuticals
MDGL
$11.4B
-19,162
ICPT
34
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-51,832
PCH
35
DELISTED
PotlatchDeltic
PCH
-42,358
PLCE icon
36
Children's Place
PLCE
$81.5M
-19,610
PSMT icon
37
Pricesmart
PSMT
$5.36B
-31,039
RHP icon
38
Ryman Hospitality Properties
RHP
$7.37B
-11,370
ADSW
39
DELISTED
Advanced Disposal Services Inc
ADSW
-28,730
IMMU
40
DELISTED
Immunomedics Inc
IMMU
-33,850
AIMT
41
DELISTED
Aimmune Therapeutics
AIMT
-222,117
CBLK
42
DELISTED
Carbon Black, Inc. Common Stock
CBLK
-22,241
BPMC
43
DELISTED
Blueprint Medicines
BPMC
-4,925
EGHT icon
44
8x8 Inc
EGHT
$299M
-30,654
EME icon
45
Emcor
EME
$36.8B
-6,451
KYNB
46
Kyntra Bio
KYNB
$27.7M
-380
FOLD
47
DELISTED
Amicus Therapeutics
FOLD
-26,853
GVA icon
48
Granite Construction
GVA
$6.15B
-97,970
HCSG icon
49
Healthcare Services Group
HCSG
$1.41B
-21,776
HOMB icon
50
Home BancShares
HOMB
$5.4B
-163,839